可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]袁耀宗.胰腺病学新进展与新技术[M].上海:上海科技文献出版社,2001:283-285.
[2]Svensson LG, Decker G,Kinsley RB.A prospective study of hyperamylasemia and pancreatitis after cardiopulmonary bypass[J].Ann Thorac Surg,1985,39(5):409-411.
[3]Paajanen H,Nuutinen P,Harmoinen A,et al.Hyperamylasemia after cardiopulmonary bypass: pancreatic cellular injury or impaired renal excretion of amylase?[J].Surgery,1998,123(5):504-510.
[4]Rattner DW,Gu ZY,Vlahakes GJ,et al.Hyperamylasemia after cardiac surgery. Incidence, significance, and management[J].Ann Surg,1989, 209(3):279-283.
[5]陈 琳,徐建军,陈 朋,等.体外循环围术期胰腺内外分泌功能的变化[J].中华胸心血管外科杂志,1998,14(5):302-303.
[6]Wan S,Arifi AA,Chan CS,et al.Is hyperamylasemia after cardiac surgery due to cardiopulmonary bypass?[J].Asian Cardiovasc Thorac Ann,2002,10(2):115-118.
[7]Fernández-del Castillo C,Harringer W.Risk factors for pancreatic cellular injury after cardiopulmonary bypass[J].N Engl J Med,1991,325(6):382-387.
[8]Ranucci M,De Toffol B,Isgrò G,et al.Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome[J].Critical Care,2006,10(6):167-168.
[9]唐玉泉,许国根,吴锦鸿,等.全身炎症反应综合征患者高淀粉酶血症在评估预后中的意义[J].内科急危重症杂志,2004,10(2):91-93.